-Arrowhead Pharmaceuticals Presents New Phase 2 Data of Zodasiran in Patients with Mixed Hyperlipidemia

Media coverage

• Title	-Arrowhead Pharmaceuticals Presents New Phase 2 Data of Zodasiran in Patients with Mixed Hyperlipidemia
  Media name/outlet	M2 PressWIRE
  Country/Territory	United States
  Date	30/05/24
  Persons	Robert Sidney Rosenson

• Title	-Arrowhead Pharmaceuticals Presents New Phase 2 Data of Zodasiran in Patients with Mixed Hyperlipidemia
  Media name/outlet	ENP Newswire
  Country/Territory	United Kingdom
  Date	30/05/24
  Persons	Robert Sidney Rosenson